SAM
EVLO

Sectoral Asset Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Sectoral Asset Management’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-31,629
Closed -$2.57M – 73
2019
Q4 		$2.57M Sell
31,629
-5,000
-14% -$559K 0.38% 55
2019
Q3 		$4.47M Buy
36,629
+3,160
+9% +$434K 0.77% 45
2019
Q2 		$6.01M Buy
33,469
+915
+3% +$148K 0.72% 50
2019
Q1 		$5.21M Buy
32,554
+12,195
+60% +$2.41M 0.63% 56
2018
Q4 		$5.3M Hold
20,359
– – 0.72% 48
2018
Q3 		$4.96M Sell
20,359
-1,516
-7% -$397K 0.53% 54
2018
Q2 		$5.16M Buy
+21,875
New +$6.38M 0.58% 50

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return